Coliform Mastitis: the facts to know | Boehringer Ingelheim US Coliform Mastitis: the facts to know | Boehringer Ingelheim US Click here to learn more about different management practices that can help you to improve your dairy herd's bottom line and productivity.
Data Show Safety of Pradaxa® (dabigatran etexilate) in Children | Boehringer Ingelheim US Data Show Safety of Pradaxa® (dabigatran etexilate) in Children | Boehringer Ingelheim US BI announces results from 2 pediatric studies of PRADAXA, presented at the ISTH Congress in Melbourne. View ISI, PI and Med Guide.
New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations
How Much Do You Know About PPID? | Boehringer Ingelheim US How Much Do You Know About PPID? | Boehringer Ingelheim US Click here to find out more about some of the common misconceptions you might have about pituitary pars intermedia dysfunction (PPID).
Pharmacy Rotations Pharmacy Rotations Click here to read testimonies from our employees who enrolled in our pharmacy rotations academic program.
Corporate Compliance Program Corporate Compliance Program Our E&C Program conforms with the principles and recommendations published in guides from various Federal agencies and industry related organizations
FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD
Protocols to Trim Mastitis in your Herd | Boehringer Ingelheim US Protocols to Trim Mastitis in your Herd | Boehringer Ingelheim US Read more on how the Boehringer Ingelheim mastitis grading chart protocols lead to creating better informed mastitis treatment decisions in livestock.
Express Scripts Adds BI Products to Roster | BI US Express Scripts Adds BI Products to Roster | BI US Read more on Express Scripts adding the Spiriva Respimat, Spiriva Handihaler and Stiolto Respimat to their commercial national preferred formulary.
Stefanie Bock Kreilinger Stefanie Bock Kreilinger Stefanie Bock-Kreilinger works in the legal department at Boehringer Ingelheim as head of corporate legal medicine, evidence and digital health.
First half 2019: High levels of investment in R&D and robust organic growth First half 2019: High levels of investment in R&D and robust organic growth First half 2019: High levels of investment in R&D and robust organic growth
Sophia Malki: A Woman on the Rise Sophia Malki: A Woman on the Rise Sophia Malki: A Woman on the Rise
Top-line Phase II Data for treatment of MASH Top-line Phase II Data for treatment of MASH Boehringer Ingelheim and Zealand Pharma announced top-line Phase II data for treatment of metabolic dysfuntion-associated steatohepatitis (MASH).
SPEVIGO approved for expanded indications in China and the US SPEVIGO approved for expanded indications in China and the US FDA approval for the Treatment of Generalized Pustular Psoriasis (GPP) in Adults and Pediatric Patients 12 Years of Age and Older Weighing at Least 40kg
Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage 3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage 3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage
Who are we? Who are we? Started in 1885 by Albert Boehringer, this independent family-owned company has grown into a top contributor in Human Pharma and Animal Health.
Global Careers Page | Boehringer Ingelheim Global Careers Page | Boehringer Ingelheim Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide.
FDA Approves Boehringer Ingelheim’s STIOLTO™ RESPIMAT® Inhalation Spray as Once-Daily Maintenance Treatment for COPD FDA Approves Boehringer Ingelheim’s STIOLTO™ RESPIMAT® Inhalation Spray as Once-Daily Maintenance Treatment for COPD FDA Approves Boehringer Ingelheim’s STIOLTO™ RESPIMAT® Inhalation Spray as Once-Daily Maintenance Treatment for COPD
Meet our 2023 HBA Luminary award winner honored for inspiring others Meet our 2023 HBA Luminary award winner honored for inspiring others Meet our 2023 HBA Luminary award winner honored for inspiring others
Talking drug discovery with our U.S. research site head, Carine Boustany Talking drug discovery with our U.S. research site head, Carine Boustany Learn about the challenges and victories of developing new medicine for conditions, like generalized pustular psoriasis (GPP) flares in adults.
Press Material Press Material Find the latest press releases from Boehringer Ingelheim on animal health or access our media pool to view BI corporate news.
Ryan Henri Rickards Ryan Henri Rickards Ryan Henry Rickards, a senior finance manager for US Animal Health Commercial Controlling team, highlights his career at Boehringer Ingelheim.